KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecuritiesSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wesbanco (WSBC) Cash & Equivalents (2016 - 2025)

Wesbanco (WSBC) has disclosed Cash & Equivalents for 15 consecutive years, with $956.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 68.29% to $956.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $956.1 million through Dec 2025, up 68.29% year-over-year, with the annual reading at $956.1 million for FY2025, 68.29% up from the prior year.
  • Cash & Equivalents hit $956.1 million in Q4 2025 for Wesbanco, down from $1.0 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.4 billion in Q1 2022 to a low of $378.6 million in Q3 2022.
  • Historically, Cash & Equivalents has averaged $735.9 million across 5 years, with a median of $597.5 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: plummeted 66.23% in 2022 and later soared 137.69% in 2025.
  • Year by year, Cash & Equivalents stood at $1.1 billion in 2021, then crashed by 63.57% to $408.4 million in 2022, then surged by 45.78% to $595.4 million in 2023, then dropped by 4.58% to $568.1 million in 2024, then surged by 68.29% to $956.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for WSBC at $956.1 million in Q4 2025, $1.0 billion in Q3 2025, and $1.2 billion in Q2 2025.